Role of Endoscopy in Palliative Treatment

  • Luca Rodella
  • Francesco Lombardo
  • Filippo Catalano
  • Angelo Cerofolini
  • Walid El Kheir
  • Giovanni de Manzoni
Part of the Updates in Surgery book series (UPDATESSURG)


Approximately 50% of patients with esophageal squamous cell carcinoma (ESCC) have metastatic disease at presentation and are candidates for palliative therapy. The median age of these patients is 65 years such that palliative surgery has a high morbidity and mortality. The main goal of endoscopic therapy in patients with advanced cancers is the palliation of dysphagia, which contributes to improved nutritional status and quality of life. Bleeding and esophago-respiratory fistulas may also be palliated. Several endoscopic palliative treatments are available for ESCC patients, as summarized in Table 18.1.


Esophageal Squamous Cell Carcinoma Stent Insertion Esophageal Squamous Cell Carcinoma Patient Stent Migration Tumor Ingrowth 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Leiper K, Morris AL (2002) Treatment of esophago-gastric tumours. Endoscopy 34:139–145PubMedCrossRefGoogle Scholar
  2. 2.
    Conio M, Blanchi S, Filiberti R, De Ceglie A (2010) Self-expanding plastic stent to palliate symptomatic tissue in/overgrowth after self-expanding metal stent placement for esophageal cancer. Dis Esophagus 23:590–596PubMedCrossRefGoogle Scholar
  3. 3.
    Vakil N, Morris AI, Marcon N et al (2001) A prospective, randomized, controller trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastr 96:1791–1796CrossRefGoogle Scholar
  4. 4.
    Verschuur EM, Steyerberg EW, Kuipers EJ et al (2007) Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 65:592–601PubMedCrossRefGoogle Scholar
  5. 5.
    Knyrim K, Wagner H, Bethge N et al (1993) A controlled trial of an expansible metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 329:1302–1307PubMedCrossRefGoogle Scholar
  6. 6.
    Homs MYV, Steyerberg EW, Eijkenboom WMH et al (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from esophageal cancer: multicentre randomised trial.Lancet 364:1497–1504PubMedCrossRefGoogle Scholar
  7. 7.
    Steyerberg EW, Homs MY, Stokvis A, et al (2005) Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection. Gastrointest Endosc 62:333–340PubMedCrossRefGoogle Scholar
  8. 8.
    Kozarek RA, Ball TJ, Brandabur JJ et al (1996) Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problem. Gastrointest Endosc 43:204–208PubMedCrossRefGoogle Scholar
  9. 9.
    Verschuur EML, Kuipers EJ, Siersema PD (2007) Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest Endosc 66:1082–1090PubMedCrossRefGoogle Scholar
  10. 10.
    Boyce HW (1984) Palliation of advanced esophageal cancer. Semin Oncol 11:186–195PubMedGoogle Scholar
  11. 11.
    Shin JH, Song HY, Ko GY et al (2004) Esophagorespiratory fistula: Long-term results of palliative treatment with covered expandable metallic stents in 61 Patients. Radiology 232:252PubMedCrossRefGoogle Scholar
  12. 12.
    Brown S, Hawes R, Mattewson K et al (1987) Endoscopic laser palliation for advanced malignant dysphagia. Gut 28:799–807CrossRefGoogle Scholar
  13. 13.
    Dumot JA, Greenwald BD (2008) Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC’s of ablative techniques. Endoscopy 40:1026–1032PubMedCrossRefGoogle Scholar
  14. 14.
    Cash BD, Johnston LR, Johnston MH (2007) Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus. World J Surg Oncol 5:34PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Greenwal BD, Cash BD (2007) Cryotherapy ablation of early stage esophageal cancer. Gastrointest Endosc 65:AB276Google Scholar
  16. 16.
    Shenfine J, McNamee P, Steen N, Bond J, Griffin SM (2009) A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer. Am J Gastroenterol 104:1674–1685PubMedCrossRefGoogle Scholar
  17. 17.
    Dallal HJ, Smith GD, Grieve DC et al (2001) A randomized trial of thermal ablative therapy vs expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 54:549–557PubMedCrossRefGoogle Scholar
  18. 18.
    Sihvo EIT, Pentikainen T, Luostarinen ME et al (2002) Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis. Eur J Surg Oncol 28:711–715PubMedCrossRefGoogle Scholar
  19. 19.
    Heier SK, Rothman KA, Heier LM, Rosenthal WS (1995) Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 109:63–72PubMedCrossRefGoogle Scholar
  20. 20.
    Saidi RF, Marcon NE (1998) Non thermal ablation of malignant esophageal strictures: Photodynamic therapy, endoscopic intratumoral injection and novel modalities. Gastrointest Endosc Clin N Am 8:465–491PubMedGoogle Scholar
  21. 21.
    Yano T, Muto M, Minashi K et al (2010) Phase II study of photodynamic therapy (PDT) for local failure after chemoradiotherapy (CRT) in patients with esophageal squamous cell carcinoma (ESCC). Gastroenterology 138:S758–S759CrossRefGoogle Scholar
  22. 22.
    Riccardi D, Allen K (1999) Nutritional management of patients with esophageal and esophagogastric junction cancer. Cancer Control 6:64–72PubMedGoogle Scholar
  23. 23.
    Stockeld D, Fagerberg J, Granstrom L et al (2001) Percutaneous endoscopic gastrostomy for nutrition in patients with oesophageal cancer. Eur J Surg 167:839–844PubMedCrossRefGoogle Scholar
  24. 24.
    Lecleire S, Di Fiore F, Antonietti M (2006) Undernutrition is predictive of early mortality after palliative self-expanding metal stents insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc 64:479–484PubMedCrossRefGoogle Scholar
  25. 25.
    Bower MR, Martin RCG (2009) Nutritional management during neoadjuvant therapy for esophageal cancer. J Surg Oncol 100:82–87PubMedCrossRefGoogle Scholar
  26. 26.
    Siddiqui AA, Loren D, Dudnick R, Kowalski T (2007) Expandable polyester silicon-covered stent for malignant esophageal structures before neoadjuvant chemoradiation: a pilot study. Dig Dis Sci 52:823–829PubMedCrossRefGoogle Scholar
  27. 27.
    Vleggar FP (2009) Stent placement in esophageal cancer as a bridge to surgery (Editorial). Gastrointest Endosc 70:620–622CrossRefGoogle Scholar
  28. 28.
    Langer FB, Schoppmann SF, Prager G et al (2010) Temporary placement of self-Expanding oesophageal stents as bridging for neoadjuvant therapy. Ann Surg Oncol 17:470–475PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Luca Rodella
    • 1
  • Francesco Lombardo
  • Filippo Catalano
  • Angelo Cerofolini
  • Walid El Kheir
  • Giovanni de Manzoni
  1. 1.Surgical Endoscopy UnitBorgo Trento HospitalVeronaItaly

Personalised recommendations